Nearly three years ago on this blog (see “A Daily Pill Against HIV Infection”, Aug. 10, 2008) I reported that research was underway to determine whether HIV infection could prevented in healthy people by giving them AIDS drugs before they became infected, not after. It’s called pre-exposure prophylaxis (PrEP), and according to a news release from the CDC, there is now convincing evidence that it works!
In one study by researchers from the University of Washington in conjunction with the CDC, a daily pill comprised of two known AIDS drugs (or a placebo) was given to nearly 5,000 “discordant couples” in Kenya and Uganda (one partner HIV-infected, the other not). Uninfected partners who took the daily pill had a 73% lower chance of becoming infected, compared to those who received the placebo. The study was stopped early because the results were so clear-cut that it was deemed unethical to continue withholding the drug from the control group. A second study by the CDC of 1,200 sexually active young adults in Botswana revealed that those who took a daily PrEP pill had a 63% lower chance of infection, compared to those who did not.
Given these recent findings, PrEP is likely to become a new standard of prophylaxis for healthy, at-risk individuals who request it. However, it should be noted that the PrEP pill has not yet been tested in pregnant women, so it may not be for everyone.
No comments:
Post a Comment